Biphasic effects of L-ascorbate on the tumoricidal activity of non-thermal plasma against malignant mesothelioma cells

Archives of Biochemistry and Biophysics

Volumn 605, Issue , 2016, Pages 109-116

  Shi, Lei ^a   Wang, Yue ^a   Ito, Fumiya ^a   Okazaki, Yasumasa ^a   Tanaka, Hiromasa ^b   Mizuno, Masaaki ^b   Hori, Masaru ^c   Richardson, Des R ^d   Toyokuni, Shinya ^a,d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Autophagy; L ascorbate; Mesothelioma; Non thermal plasma (NTP); Reactive oxygen species (ROS)

Indexed keywords

ARGON; ASCORBIC ACID; DEFEROXAMINE; DICHLORODIHYDROFLUORESCEIN DIACETATE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; PLASMA GAS; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CELL VIABILITY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALIGNANT MESOTHELIOMA; OXIDATIVE STRESS; PLASMA GAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; APOPTOSIS; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; LUNG NEOPLASMS; MESOTHELIOMA; TEMPERATURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; PLASMA GASES; REACTIVE OXYGEN SPECIES; TEMPERATURE;

EID: 84971624247     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2016.05.016     Document Type: Article

References (50)

1. [1] IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens; Part C: Arsenic, Metals, Fibres, and Dusts, Lyon. 2012, 219–309 France.
2. [2] Chew, S.H., Toyokuni, S., Malignant mesothelioma as an oxidative stress-induced cancer: an update. Free Radic. Biol. Med. 86 (2015), 166–178.
3. [3] Toyokuni, S., Mechanisms of asbestos-induced carcinogenesis. Nagoya J. Med. Sci. 71 (2009), 1–10.
4. [4] Nature Editorial, Editorials this week: asbestos scandal. Nature, 468, 2010, 868.
5. [5] Diandini, R., Takahashi, K., Park, E.K., Jiang, Y., Movahed, M., Le, G.V., Lee, L.J., Delgermaa, V., Kim, R., Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. Am. J. Ind. Med. 56 (2013), 993–1000.
6. [6] Robinson, B., Lake, R., Advances in malignant mesothelioma. N. Engl. J. Med. 353 (2005), 1591–1603.
7. [7] Reid, A., de Klerk, N.H., Magnani, C., Ferrante, D., Berry, G., Musk, A.W., Merler, E., Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 69 (2014), 843–850.
8. [8] Beckett, P., Edwards, J., Fennell, D., Hubbard, R., Woolhouse, I., Peake, M.D., Demographics, management and survival of patients with malignant pleural mesothelioma in the national lung cancer audit in England and Wales. Lung Cancer 88 (2015), 344–348.
9. [9] Hiddinga, B.I., Rolfo, C., van Meerbeeck, J.P., Mesothelioma treatment: are we on target? A review. J. Adv. Res. 6 (2015), 319–330.
10. [10] Fridman, G., Friedman, G., Gutsol, A., Shekhter, A.B., Vasilets, V.N., Fridman, A., Applied plasma medicine. Plasma Process. Polym. 5 (2008), 503–533.
11. [11] Okazaki, Y., Wang, Y., Tanaka, H., Mizuno, M., Nakamura, K., Kajiyama, H., Kano, H., Uchida, K., Kikkawa, F., Hori, M., Toyokuni, S., Direct exposure of non-equilibrium atmospheric pressure plasma confers simultaneous oxidative and ultraviolet modifications in biomolecules. J. Clin. Biochem. Nutr. 55 (2014), 207–215.
12. [12] Oda, T., Non-thermal plasma processing for environmental protection: decomposition of dilute VOCs in air. J. Electrostat. 57 (2003), 293–311.
13. [13] Kim, H.H., Nonthermal plasma processing for air-pollution control: a historical review, current issues, and future prospects. Plasma Process. Polym. 1 (2004), 91–110.
14. [14] Fridman, G., Brooks, A.D., Balasubramanian, M., Fridman, A., Gutsol, A., Vasilets, V.N., Ayan, H., Friedman, G., Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Process. Polym. 4 (2007), 370–375.
15. [15] Iseki, S., Ohta, T., Aomatsu, A., Ito, M., Kano, H., Higashijima, Y., Hori, M., Rapid inactivation of Penicillium digitatum spores using high-density nonequilibrium atmospheric pressure plasma. Appl. Phys. Lett., 96, 2010, 153704.
16. [16] Isbary, G., Morfill, G., Schmidt, H.U., Georgi, M., Ramrath, K., Heinlin, J., Karrer, S., Landthaler, M., Shimizu, T., Steffes, B., A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br. J. Dermatol. 163 (2010), 78–82.
17. [17] Tanaka, H., Mizuno, M., Ishikawa, K., Kondo, H., Takeda, K., Hashizume, H., Nakamura, K., Utsumi, F., Kajiyama, H., Kano, H., Okazaki, Y., Toyokuni, S., Akiyama, S., Maruyama, S., Yamada, S., Kodera, Y., Kaneko, H., Terasaki, H., Hara, H., Adachi, T., iida, M., Yajima, I., Kato, M., Kikkawa, F., Hori, M., Plasma with high electron density and plasma-activated medium for cancer treatment. Clin. Plasma Med. 3 (2015), 72–76.
18. [18] Toyokuni, S., Okamoto, K., Yodoi, J., Hiai, H., Persistent oxidative stress in cancer. FEBS Lett. 358 (1995), 1–3.
19. [19] Toyokuni, S., Iron and thiols as two major players in carcinogenesis: friends or foes?. Front. Pharmacol., 5, 2014, 200.
20. [20] Utsumi, F., Kajiyama, H., Nakamura, K., Tanaka, H., Mizuno, M., Ishikawa, K., Kondo, H., Kano, H., Hori, M., Kikkawa, F., Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS One, 8, 2013, e81576.
21. [21] Utsumi, F., Kajiyama, H., Nakamura, K., Tanaka, H., Hori, M., Kikkawa, F., Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma. Springerplus, 3, 2014, 398.
22. [22] Kang, S.U., Cho, J.H., Chang, J.W., Shin, Y.S., Kim, K.I., Park, J.K., Yang, S.S., Lee, J.S., Moon, E., Lee, K., Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species. Cell Death Dis., 5, 2014, e1056.
23. [23] Vandamme, M., Robert, E., Lerondel, S., Sarron, V., Ries, D., Dozias, S., Sobilo, J., Gosset, D., Kieda, C., Legrain, B., Pouvesle, J.M., Pape, A.L., ROS implication in a new antitumor strategy based on non-thermal plasma. Int. J. Cancer 130 (2012), 2185–2194.
24. [24] Brulle, L., Vandamme, M., Ries, D., Martel, E., Robert, E., Lerondel, S., Trichet, V., Richard, S., Pouvesle, J.M., Le Pape, A., Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PLoS One, 7, 2012, e52653.
25. [25] Takemura, Y., Satoh, M., Satoh, K., Hamada, H., Sekido, Y., Kubota, S., High dose of ascorbic acid induces cell death in mesothelioma cells. Biochem. Biophys. Res. Commun. 394 (2010), 249–253.
26. [26] Du, J., Cullen, J.J., Buettner, G.R., Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim. Biophys. Acta 1826 (2012), 443–457.
27. [27] Toyokuni, S., Sagripanti, J.L., Induction of oxidative single- and double-strand breaks in DNA by ferric citrate. Free Radic. Biol. Med. 15 (1993), 117–123.
28. [28] Toyokuni, S., Sagripanti, J.-L., Association between 8-hydroxy-2’-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic. Biol. Med. 20 (1996), 859–864.
29. [29] Evans, M.K., Tovmasyan, A., Batinic-Haberle, I., Devi, G.R., Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death. Free Radic. Biol. Med. 68 (2014), 302–314.
30. [30] Iwasaki, M., Inui, H., Matsudaira, Y., Kano, H., Yoshida, N., Ito, M., Hori, M., Nonequilibrium atmospheric pressure plasma with ultrahigh electron density and high performance for glass surface cleaning. Appl. Phys. Lett., 92, 2008, 081503.
31. [31] Jiang, L., Akatsuka, S., Nagai, H., Chew, S.H., Ohara, H., Okazaki, Y., Yamashita, Y., Yoshikawa, Y., Yasui, H., Ikuta, K., Sasaki, K., Kohgo, Y., Hirano, S., Shinohara, Y., Kohyama, N., Takahashi, T., Toyokuni, S., Iron overload signature in chrysotile-induced malignant mesothelioma. J. Pathol. 228 (2012), 366–377.
32. [32] Suzuki, K., Kazui, T., Yoshida, M., Uno, T., Kobayashi, T., Kimura, T., Yoshida, T., Sugimura, H., Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro. Jpn. J. Clin. Oncol. 29 (1999), 323–331.
33. [33] Yamashita, K., Nagai, H., Toyokuni, S., Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers. Lab. Invest. 95 (2015), 749–764.
34. [34] Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., Yoshimori, T., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19 (2000), 5720–5728.
35. [35] Mishra, P.K., Khan, S., Bhargava, A., Panwar, H., Banerjee, S., Jain, S.K., Maudar, K.K., Regulation of isocyanate-induced apoptosis, oxidative stress, and inflammation in cultured human neutrophils: isocyanate-induced neutrophils apoptosis. Cell. Biol. Toxocol. 26 (2010), 279–291.
36. [36] Murrow, L., Debnath, J., Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu. Rev. Pathol. 8 (2013), 105–137.
37. [37] Klionsky, D.J., Abdelmohsen, K., Abe, A., Adedin, M.J., Abeliovich, H., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (third ed.). Autophagy 12 (2016), 1–222.
38. [38] Pathology of Asbestos-associated Diseases, second ed., 2004, Springer Verlag, New York.
39. [39] Beyer, R.E., The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J. Bioenerg. Biomembr. 26 (1994), 349–358.
40. [40] Rodrigues, J.V., Gomes, C.M., Enhanced superoxide and hydrogen peroxide detection in biological assays. Free Radic. Biol. Med. 49 (2010), 61–66.
41. [41] Williams, N.H., Yandell, J.K., Outer-sphere electron-transfer reactions of ascorbate anions. Aust. J. Chem. 35 (1982), 1133–1144.
42. [42] McCarty, M.F., Contreras, F., Increasing superoxide production and the labile iron pool in tumor cells may sensitize them to extracellular ascorbate. Front. Oncol., 4, 2014, 249.
43. [43] Clement, M.V., Ramalingam, J., Long, L.H., Halliwell, B., The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid. Redox. Signal. 3 (2001), 157–163.
44. [44] Richardson, D.R., Ponka, P., The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331 (1997), 1–40.
45. [45] Chen, Q., Espey, M.G., Sun, A.Y., Lee, J.H., Krishna, M.C., Shacter, E., Choyke, P.L., Pooput, C., Kirk, K.L., Buettner, G.R., Levine, M., Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 8749–8754.
46. [46] Hans Goldenberg, E.S., Transport of vitamin C in animal and human cells. J. Bioenerg. Biomembr. 26 (1994), 359–367.
47. [47] Harrison, F.E., May, J.M., Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 46 (2009), 719–730.
48. [48] Efeyan, A., Zoncu, R., Chang, S., Gumper, I., Snitkin, H., Wolfson, R.L., Kirak, O., Sabatini, D.D., Sabatini, D.M., Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493 (2013), 679–683.
49. [49] Lamy, L., Ngo, V.N., Emre, N.C., Shaffer, A.L. 3rd., Yang, Y., Tian, E., Nair, V., Kruhlak, M.J., Zingone, A., Landgren, O., Staudt, L.M., Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell 23 (2013), 435–449.
50. [50] Toyokuni, S., Role of iron in carcinogenesis. Cancer Sci. 100 (2009), 9–16.